-
1.
公开(公告)号:EP4433435A1
公开(公告)日:2024-09-25
申请号:EP22839030.8
申请日:2022-11-16
申请人: CarbonBuilt
发明人: MEHDIPOUR, Iman
CPC分类号: C04B28/006 , Y02W30/91
-
公开(公告)号:EP4401830A1
公开(公告)日:2024-07-24
申请号:EP22870981.2
申请日:2022-09-16
发明人: MILLER, Eric C.
IPC分类号: A61P3/10 , A23D9/007 , A23L33/12 , A23L33/175 , C11C3/08
CPC分类号: A61P3/10 , A23D9/007 , A23L33/12 , A23L33/175 , A23L33/15 , A23L33/115 , A23L33/18 , A23L33/19 , A23L33/21 , A23V2002/0020130101
-
公开(公告)号:EP4401731A1
公开(公告)日:2024-07-24
申请号:EP22818882.7
申请日:2022-09-16
发明人: LEE, Pei-Jou , CHIU, Yi-Tsui , HSIEH, Fu-Tan
IPC分类号: A61K31/437 , A61K39/00 , A61K45/06 , A61P35/00
CPC分类号: A61K31/437 , A61K45/06 , A61P35/00 , C07K16/2818 , A61K39/3955 , C07K16/2878 , C07K16/2803
-
公开(公告)号:EP4363086A1
公开(公告)日:2024-05-08
申请号:EP22834318.2
申请日:2022-07-01
申请人: Gradiant Corporation
发明人: LOKARE, Omkar , STOVER, Richard
-
公开(公告)号:EP4327882A2
公开(公告)日:2024-02-28
申请号:EP24150802.7
申请日:2018-09-07
IPC分类号: A61P35/00
摘要: Compounds, compositions and methods are provided for the inhibition of ENPP 1. Aspects of the subject methods include contacting a sample with a ENPP1 inhibitor to inhibit cGAMP hydrolysis activity of ENPP1. In some cases, the ENPP1 inhibitor is cell impermeable. Also provided are compositions and methods for treating cancer. Aspects of the methods include administering to a subject a therapeutically effective amount of a ENPP 1 inhibitor to treat the subject for cancer. In certain cases, the cancer is a solid tumor cancer. Also provided are methods of administering radiation therapy to a subject either before or after administering an ENPP1 inhibitor. The radiation therapy can be administered at a dosage and/or frequency effective to reduce radiation damage to the subject. In certain cases, the method is performed in combination with a chemotherapeutic agent, or a checkpoint inhibitor, or both.
-
公开(公告)号:EP4326713A1
公开(公告)日:2024-02-28
申请号:EP22787519.2
申请日:2022-04-12
发明人: CAI, Sui Xiong , TIAN, Ye Edward , WANG, Xiaozhu
IPC分类号: C07D401/14 , C07D471/04 , A61K31/435 , A61P29/00 , A61P25/18
-
公开(公告)号:EP4281504B1
公开(公告)日:2024-01-17
申请号:EP22812541.5
申请日:2022-10-27
发明人: GOMIS, Maria , MINES, Paul , LONGDON, Tony , ARNILLAS, Daniel
IPC分类号: C08L67/04
-
公开(公告)号:EP3160475B1
公开(公告)日:2024-01-03
申请号:EP15810951.2
申请日:2015-06-22
发明人: BLATT, Lawrence M. , BEIGELMAN, Leonid , DYATKINA, Natalia , SYMONS, Julian Alexander , SMITH, David Bernard
IPC分类号: A61K31/7068 , A61K31/7072 , A61K31/7076 , A61K31/708 , A61P31/14
-
公开(公告)号:EP4247233A1
公开(公告)日:2023-09-27
申请号:EP21895592.0
申请日:2021-11-18
申请人: Cision Vision, Inc.
发明人: LI, Zhongming
-
公开(公告)号:EP4234017A2
公开(公告)日:2023-08-30
申请号:EP23170487.5
申请日:2016-01-21
申请人: MyoKardia, Inc.
发明人: OSLOB, Johan , AUBELE, Danielle , KIM, Jae , MCDOWELL, Robert , SONG, Yonghong , SRAN, Arvinder , ZHONG, Min
IPC分类号: A61P9/04
摘要: The present invention provides novel 4-methylsulphone-substituted piperidine urea compounds that are useful for the treatment of dilated cardiomyopathy (DCM) and conditions associated with left and/or right ventricular systolic dysfunction or systolic reserve. The synthesis and characterization of the compounds is described, as well as methods for treating DCM and other forms of heart disease.
-
-
-
-
-
-
-
-
-